Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-10-18 00:00:00 ET · period of report 2022-10-14 · accession 0001567619-22-018586 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-18 | 2022-10-14 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale | $89.89 | -4,000 | 324.3K | -1% | -$359.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-14 | S | D | 4,000 | $89.89 | 324,324 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. |